Cleared Traditional

K820189 - CARBAMAZEPINE ASSAY (FDA 510(k) Clearance)

Feb 1982
Decision
18d
Days
Class 2
Risk

K820189 is an FDA 510(k) clearance for the CARBAMAZEPINE ASSAY. This device is classified as a Enzyme Immunoassay, Carbamazepine (Class II - Special Controls, product code KLT).

Submitted by Syva Co. (Mchenry, US). The FDA issued a Cleared decision on February 12, 1982, 18 days after receiving the submission on January 25, 1982.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3645.

Submission Details

510(k) Number K820189 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 1982
Decision Date February 12, 1982
Days to Decision 18 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code KLT — Enzyme Immunoassay, Carbamazepine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3645